Back
Bioxytran Drug Shows 100% Viral Clearance in Phase 2 Trial
Back
Stock News
Themes
Bioxytran Drug Shows 100% Viral Clearance in Phase 2 Trial
Bioxytran Drug Shows 100% Viral Clearance in Phase 2 Trial
Edgen Stock
·
Feb 11 2026, 11:11
Share to
Share to
Copy link
BIXT
+2.67%
source:
[1] Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-M
Recommend
Apple Stock Climbs as Investors Shun Big Tech's $650B AI Spending
Feb 18 2026, 00:32
Similarweb Swings to Profit, Beating Q4 Estimates
Feb 17 2026, 23:58
Hormel Sells Turkey Business, Reaffirms 2026 Guidance
Feb 17 2026, 23:57
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Themes
Crypto Comparison
Home Page
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
US Market
HK Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2026 Finture Development Limited. All rights reserved
Edgen Stock·Feb 11 2026, 11:11Edgen Stock·Feb 11 2026, 11:11
Edgen Stock·Feb 11 2026, 11:11